Related Experiment Videos

Decrease in the activity of hepatic microsomal drug-metabolizing enzymes in tumor-bearing nude mice

Gan
|December 1, 1982
PubMed

Insights

Drug-metabolizing enzyme activity in nude mice with tumors significantly decreased. This reduction is independent of immune response or cachexia, suggesting a direct tumor-related effect on liver enzymes.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Cancer Biology

Background:

  • Hepatic microsomal drug-metabolizing enzymes are crucial for xenobiotic and endogenous compound processing.
  • Tumor-bearing hosts often exhibit altered drug metabolism, impacting treatment efficacy.
  • Nude mice (BALB/c-nu/nu) are valuable models for studying human tumors due to their immunodeficiency.

Purpose of the Study:

  • To investigate the impact of tumors on hepatic microsomal drug-metabolizing enzyme activities in nude mice.
  • To determine if observed enzyme activity changes are linked to immunoreactivity or cachexia.

Main Methods:

  • Assessed cytochrome P-450 content in tumor-bearing nude mice.
  • Measured activities of key drug-metabolizing enzymes: cyclophosphamide oxidase, benzo[a]pyrene hydroxylase, aniline hydroxylase, and benzphetamine N-demethylase.
  • Compared enzyme levels and activities in tumor-bearing mice with control groups (implied).

Main Results:

  • Marked decreases in cytochrome P-450 content were observed.
  • Significant reductions in the activities of cyclophosphamide oxidase, benzo[a]pyrene hydroxylase, aniline hydroxylase, and benzphetamine N-demethylase were noted.
  • These enzyme alterations occurred in nude mice bearing tumors of both human and nude mouse origin.

Conclusions:

  • Tumor burden in nude mice leads to a significant decrease in hepatic microsomal drug-metabolizing enzyme activities.
  • The observed reductions are not attributable to the host's immune response or cachexia.
  • These findings suggest a direct influence of the tumor on the metabolic capacity of the liver.

Related Concept Videos